Sutro Biopharma Inc (NAS:STRO)
$ 2.75 0.1 (3.77%) Market Cap: 226.76 Mil Enterprise Value: -144.87 Mil PE Ratio: 0 PB Ratio: 2.04 GF Score: 64/100

Sutro Biopharma Inc Deep Dive Research Forum: Next-Gen Innovations in ADCs Transcript

Jul 20, 2022 / 08:30PM GMT
Release Date Price: $6.14 (+5.32%)
Operator

Good afternoon, and welcome to the Sutro Biopharma Virtual Deep Dive Research Forum, Next-Gen Innovations in ADCs. (Operator Instructions) Please be advised that the call is being recorded at the company's request and will be available on the company's website for at least 30 days.

I would now like to turn the call over to Bill Newell, Chief Executive Officer at Sutro Biopharma. Sir, please go ahead.

William J. Newell
Sutro Biopharma, Inc. - CEO & Director

Thank you all, operator. Good afternoon, everyone, and thank you for joining us.

With me on the call today are Dr. Trevor Hallam, our President of Research and Chief Scientific Officer; Dr. Kristin Bedard, our Vice President, Discovery; Dr. Shabbir Anik, our Chief Technical Operations Officer; and Dr. Venkatesh Srinivasan, our Senior Vice President, Process and Analytical Development.

Before we start, I would like to remind you that today's call will include forward-looking statements. These forward-looking statements are based on Sutro's expectations and assumptions as of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot